Dr. Wen Hwa Lee (PhD), CEO of Action Against AMD, is a molecular and structural biologist with a wide international network in drug discovery, including charities, academia, industry and government agencies. Previously at the University of Oxford, Lee is an experienced leader in setting up partnerships and alliances with multiple stakeholders to accelerate discoveries for drug discovery. He designed and implemented several strategies in two of the largest and most successful international public-private partnerships for drug discovery – the Structural Genomics Consortium and the European Lead Factory. Along with his scientific endeavors, Lee also advised high-level government representatives from different countries and charitable institutions on policy and strategy to integrate scientific, societal and economic impact.
Action Against AMD